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A reparative approach of disrupted epithelium in obstructive airway diseases, namely
asthma and chronic obstructive pulmonary disease (COPD), may afford protection
and long-lasting results compared to conventional therapies, e.g., corticosteroids or
immunosuppressant drugs. Here, we propose the polyamine spermidine as a novel
therapeutic agent in airways diseases, based on a recently identified mode of action:
T-cell protein tyrosine phosphatase (TCPTP) agonism. It may include and surpass
single-inhibitors of stress and secondary growth factor pathway signaling, i.e., the
new medicinal chemistry in lung diseases. Enhanced polyamine biosynthesis has
been charged with aggravating prognosis by competing for L-arginine at detriment
of nitric oxide (NO) synthesis with bronchoconstrictive effects. Although excess
spermine, a higher polyamine, is harmful to airways physiology, spermidine can
pivot the cell homeostasis during stress conditions by the activation of TCPTP. In
fact, the dephosphorylating activity of TCPTP inhibits the signaling cascade that leads
to the expression of genes involved in detachment and epithelial-to-mesenchymal
transition (EMT), and increases the expression of adhesion and tight junction proteins,
thereby enhancing the barrier functionality in inflammation-prone tissues. Moreover, a
further beneficial effect of spermidine may derive from its ability to promote autophagy,
possibly in a TCPTP-dependent way. Since doses of spermidine in the micromolar range
are sufficient to activate TCPTP, low amounts of spermidine administered in sustained
release modality may provide an optimal pharmacologic profile for the treatment of
obstructive airway diseases.
Keywords: TCPTP, spermidine, chronic airway disorders, FGF, TGF, stress growth factors, epithelial to
mesenchymal transition, autophagy
INTRODUCTION
Asthma and chronic obstructive pulmonary disease (COPD) are widespread respiratory disorders,
both responding to bronchodilator drugs and to a reduction of toxic insults, e.g., smoking
cessation. However, lung function is fully reversible only in subjects with asthma, whilst COPD
shows a steady progress pattern. Both asthma and COPD are inflammatory disorders, but their
inflammatory patterns differ: the mast-cell/CD4+ T cells/eosinophils axis prevails in asthma,
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whereas neutrophils/CD8+ T cells (Barnes, 2008) and premature
lung senescence (Chilosi et al., 2013) associated to the activation
of the receptors of advanced glycation end-products (RAGE;
Robinson et al., 2012) fuel COPD. Indeed, most treatments
for COPD and asthma are presently focused on suppressing
the inflammatory cascades. However, the two conditions share
other similarities, such as excessive mucus secretion, impaired
epithelial barrier, and obstructive condition. Although the
integrity of impaired airways is deemed to be a key player in
initiating and determining the clinical outcomes in respiratory
diseases (Tam et al., 2011), little attention is paid to its
control.
The expression of genes that encode junctional proteins,
such as claudin-1 and zona occludens (ZO)-1, and adherent
junctional E-cadherin is repressed in “leaky” airways (Balda
and Matter, 2009; Pohl et al., 2009; Shaykhiev et al., 2011).
In turn, defective tight junctions allow the penetration of
further toxic insults. The susceptibility to environmental injury
leads to the persistent TH2-activation of lymphoid cells,
whose interplay with myeloid cells results in the increase of
circulating and intra-cellular levels of transforming growth factor
(TGF)-β.
Stressor autocrine pathways induced by TGF-β upregulation
lead to epithelial-to-mesenchymal transition (EMT; Grainge
and Davies, 2013), i.e., the loss of epithelial phenotype and
the acquisition of mesenchymal phenotype, which plays an
important role in the airway remodeling that occurs in chronic
bronchial diseases (Pain et al., 2014). Aberrant epithelium
repair prompts the accumulation of fibroblasts which initiate
the deposition of extracellular matrix (ECM), thus sustaining
persistent bronchial obstruction.
FIGURE 1 | Single-step pharmacologic strategies in chronic respiratory disease of approved and under-development EGFR pathway inhibitors
compared to spermidine activity. Single step strategies: (i) anti-EGFR monoclonal antibodies that bind the extracellular domain of EGFR and prevent downstream
activation (cetuximab, trastuzumab); (ii) tyrosine kinase inhibitors targeting the intracellular portion of EGF receptors to block autophosphorylation (erlotinib, gefitinib,
lapatinib, HKI-272, BIBW-2948); (iii) Inhibitors of specific downstream EGFR signaling pathway (ARRY-142886, PX-866, ruxolitinib, perifosine, selumetinib, and
sorafenib). Acting on TCPTP, spermidine can exert multiple direct and indirect effects.
Other cytokines, such as tumor necrosis factor (TNF)-α,
via Src kinases activation, concur to determining the barrier
dysfunction observed in chronic airways diseases (Hardyman
et al., 2013). The consequence is a chronic, self-sustained wound
scenario dominated by the secretion of secondary stress growth
factors (Heijink et al., 2012; Gan et al., 2013; Hardyman et al.,
2013) which fuel the progression of airway wall remodeling
(Boxall et al., 2006).
Impaired airway epithelial integrity also parallels the higher
expression of epidermal growth factor receptor (EGFR) in
airway epithelia (Burgel and Nadel, 2008). Dimeric EGFR
cooperates with TGF-β in activating one or more downstream
effectors, including the MEK/ERK (MAPK kinase/extracellular
signal-regulated kinase), PI3K/AKT (phosphatidylinositol-
3-kinase/protein kinase B), and STAT (signal transducer
and activator of transcription) pathways through receptor
autophosphorylation and cytoplasmic protein binding (Jorissen
et al., 2003). Therefore, EGFR and its downstream signaling
effectors have been targeted by a number of new drug candidates
(Figure 1).
Many metabolites are involved in airway remodeling in
obstructive diseases, e.g., the natural polyamines (PA) spermidine
and spermine, although their role as either worsening or
alleviating factors is complex and still under debate (Hoet and
Nemery, 2000; Erle and Sheppard, 2014). In fact, the EMT
transition and barrier disruption that are present in airway
diseases parallel PA/spermidine scarcity (Prunotto et al., 2010).
Conversely, spermidine alone may be able to moderate most
consequences triggered by EGFR and its downstream effectors
via agonism on T-cell protein tyrosine phosphatase (TCPTP;
Figure 1), as better detailed hereafter.
Frontiers in Pharmacology | www.frontiersin.org 2 June 2016 | Volume 7 | Article 147
Ghisalberti et al. Spermidine in Airway Diseases
ROLE OF POLYAMINES IN LUNG CELL
PHYSIOLOGY
Spermidine and spermine are the most common and important
members of PA, small organic polycations ubiquitously
present in nature. Spermidine [NH2(CH2)4NH(CH2)3NH2]
and spermine [NH2(CH2)3NH(CH2)4NH(CH2)3NH2] are
sequentially derived from putrescine [NH2(CH2)4NH2].
Their biosynthesis requires decarboxylated S-adenosyl-L-
methionine (DcAdoMet) as aminopropyl group donor and
the enzymatic activity of spermidine synthase and spermine
synthase, respectively. PA are essential for living cells, where
they specifically interact with DNA, RNA, histones, and other
proteins, thus affecting gene expression and biological protein
activity (Pegg, 2009; Igarashi and Kashiwagi, 2010). Each PA has
an array of distinctive properties. A unique role of spermidine in
eukaryotes is the covalent modification of eukaryotic initiation
factor 5A (eIF5A), resulting in an unusual amino acid, hypusine
[Nǫ-(4-amino-2-hydroxybutyl)lysine] (Park, 2006). eIF5A and
modified hypusine are necessary for the viability and growth of
mammalian cells (Nishimura et al., 2012). PA are synthesized
by a pathway involving L-arginine metabolism via arginase and
ornithine decarboxylase (ODC) and their synthesis is regulated
through a limitative feed-back control activated by increased PA
level through antizyme (AZ)-mediated ODC down-regulation
(Figure 2). However, L-arginine, via the nitric oxide synthase
(NOS) pathway, also supports the formation of NO, which
is key for the maintenance of airway tone (Ray et al., 2014).
The balance between NOS isozymes and arginases regulates
airways tone (Meurs et al., 2003). In particular, the constitutive
neuronal and endothelial isoforms (nNOS and eNOS) support
lung smooth muscle tone and relaxation. Noteworthy, NO
scarcity may be compensated by the presence of inducible
NOS (iNOS), which is upregulated in airway inflammation,
e.g., in asthma (North et al., 2010; North and Scott, 2011).
A negative role for PA in lung diseases was suggested by
studies showing that an increase in the arginase/PA pathway
at the expense of the NOS/NO output exacerbates COPD and
asthma (Bergeron et al., 2007). Actually, enhanced arginase
activity decreases L-arginine availability, thereby causing NO
deficiency that contributes to airway hyper-responsiveness
(Morris, 2013; North et al., 2013). Following the suggestion
that the NOS-to-arginase shift may play a negative role in
airway remodeling (Meurs et al., 2002, 2003), PA biosynthesis
FIGURE 2 | Competing pathways in L-arginine metabolism. Arginine is a substrate for both NOS, yielding NO and L-citrulline, and for arginase, to produce
ornithine and urea. Ornithine is then metabolized by ODC to putrescine, or by OAT to provide proline, a major precursor for collagen biosynthesis. Putrescine supplies
the building blocks of the higher polyamines spermidine and spermine, synthetized by SpdS and SpmS, respectively. ODC activity is controlled by AZ, which in turn
accumulates via mechanisms triggered by increasing polyamine levels. The polyamine pool is also back-regulated via acetylation and degradation by SSAT and PAO.
Both spermine and, to a lesser extent, spermidine, inhibit NOS activity. NOS inhibition can further derive from the feedback effect of NOHA, the intermediate in NO
production. Arginine is also incorporated into proteins, where it can be mono- or di-methylated by PRMT to free MMA, ADMA, and SDMA upon proteolysis. ADMA
acts as an endogenous inhibitor of NOS, and SDMA competes in L-arginine uptake. AZ, antizyme; NO, nitric oxide; NOS, nitric oxide synthase; NOHA,
Nω-hydroxy-L-arginine; PRMT, protein arginine methyltransferases; Protein-R-(CH3)n, n-methyl-arginine-containing proteins; MMA, monomethyl arginine; ADMA,
asymmetric dimethylarginine; SDMA, symmetric dimethylarginine; OAT, ornithine aminotransferase; ODC, ornithine decarboxylase; P5C, L-pyrroline-5- carboxylate;
P5CR, pyrroline-5-carboxylate reductase; SpdS, spermidine synthase; SpmS, spermine synthase; PAO, polyamine oxidase; SSAT,
spermidine/spermine-N1-acetyltransferase; N1-AcSpd, N1-acetylspermidine; N1-AcSpm, N1-acetylspermine.
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has been proposed as a new therapeutic target (Pera et al.,
2014).
The hypothesis that envisages a pathogenic role for PA
is also supported by the findings of a study describing
the integrin-mediated localization of spermidine/spermine-N1-
acetyltransferase (SSAT, the key PA catabolic enzyme) in close
proximity to the lipid kinase phosphatidylinositol phosphate
(PIP)5K1γ, the main source of phosphatidylinositol 2 phosphate
in airway smooth muscle, whose activity is regulated by PA.
It has been shown that proper assembly of the integrin-SSAT-
PIP5K1γ complex results in efficient PA catabolism and airways
contraction inhibition, whereas administration of the higher-
order PA spermine enhanced contraction (Chen et al., 2004,
2012). However, it should be noted that these studies used
exposure doses (100 µM) at least 10-fold higher than physiologic
levels of PA. It is also important to consider that exogenously
added PA—even at low doses—can actually inhibit intracellular
PA biosynthesis by negative feed-back, as mentioned above,
possibly resulting in increased availability of L-arginine and its
shift toward NO formation.
A further element of complexity derives from the occurrence
of L-arginine derivatives, such asymmetric and symmetric
dimethyl arginine (ADMA and SDMA, respectively) which
represent degradation products of proteins containing post-
translationally methylated arginine residues (Scott et al., 2011,
2014; Holguin et al., 2013; Scott and Grasemann, 2013). The
accumulation of both ADMA and SDMA can lead to reduced
NOS activity. ADMA is a NOS endogenous inhibitor associated
with lung disease (Zakrzewicz and Eickelberg, 2009), whereas
SDMA contributes to the NO imbalance by competing with the
cationic amino acid transporter-2 for L-arginine uptake (North
and Scott, 2011). ADMA levels range between 50 and 75 nM,
whereas its potency in NOS inhibition is 100-fold higher than
that of spermine. Hence, lung diseases such as acute respiratory
dysfunction triggered by NO scarcity might be the result of
proteolytic waste of L-arginine and subsequent accumulation of
these arginine derivatives, rather than derive from PA production
favored by the NOS-to-arginase shift.
THE KEY DRIVING FORCE IN EPITHELIAL
STABILIZATION: TCTPT AGONISM
Although some of the studies presented above suggest a negative
role for PA in airways diseases, we propose that one specific PA,
i.e., spermidine, may play a positive (possibly therapeutic) role
in pulmonary disarray by virtue of two mechanisms: interaction
with TCPTP and activation of autophagy.
TCPTP (aka PTPN2), a phosphatase expressed in most
mammalian cells, is an intracellular suppressor of metastatic
and inflammatory signaling pathways. The two TCPTP isoforms,
resulting from differential splicing, suppress a variety of signaling
substrates including receptor tyrosine kinases (RTKs), such as
EGFR, insulin growth factor receptor (IGFR), platelet-derived
growth factor receptor (PDGR), colony-stimulating factor-1
(CSF-1) receptor, and vascular endothelial growth factor receptor
(VEGFR), as well as mitogen-activated protein kinases (MAPKs).
Moreover, TCPTP quenches signaling mediated by nuclear (e.g.,
STAT-1, -3, -5, 6), and cytoplasmic proteins (e.g., JAK1, JAK2,
p52-Shc, Src-tyrosine kinases; Mattila, 2009; Muppirala et al.,
2013). The dephosphorylation of key targets in downstream
signaling pathways leads to the inactivation of pro-inflammatory
responses induced by IFN-γ, TNF-α, and IL-6. TCPTP proteins
impact airway physiology inmultifarious ways (Figure 3), mostly
by quenching TGF-βR and EGFR (Tiganis et al., 1999; Mattila
et al., 2005) and relevant post-receptor signaling intermediates,
thus providing an anti-mitogenic effect (Chernoff, 1999; Rajeeve
et al., 2013).
Recently, a high-throughput assay aimed at selecting novel
TCPTP agonists screened as many as 64,280 small molecules to
identify finally two leads, mitoxantrone and spermidine, both
active at low micromolar levels (Mattila et al., 2010). Modalities
of action were elucidated: the former directly binds to TCPTP
catalytic domain, whereas spermidine agonism does not require
interference with TCPTP active center (Ylilauri et al., 2013).
This study showing a direct interaction between spermidine
and TCPTP may provide a unifying explanatory view of a
vast array of spermidine biological features, firstly described
in human dermal fibroblasts and still lacking an explanation,
such as the down-regulation of matrix metalloproteinase-2,
histone acetyltransferase, p-ERK, p-JNK, and NF-κB activity and
expression, and increase in histone deacetylase 1 and sirtuin 1
(Park and Kim, 2012).
Indeed, parallel studies confirmed that the increase of TCPTP
level and enzymatic activity driven by spermidine were coupled
with decreased phosphorylation of the downstream transducers
in IFN-γ cascades (Penrose et al., 2013). TCPTP activation in
response to stress factors was also observed in human THP-
1 monocytes challenged with IFN-γ. Exogenous spermidine
enhanced TCPTP level, reduced phosphorylation of STAT-
1,3, p38-MAPK, and lowered secretion of ICAM-1, monocyte
chemoattractant protein (MCP)-1, and IL-6 in a TCPTP-
dependent manner, as the modulatory effects of spermidine
against IFN-γ exposure were absent in TCPTP-knockdown cells
(Moron et al., 2013).
LESSONS FROM THE INTESTINAL
EPITHELIUM
The connection of PA with intestinal repair, replacement and
stabilization has been investigated for 40 years (Luk and Yang,
1987; Wang and Johnson, 1990, 1992; McCormack and Johnson,
1991; Johnson and McCormack, 1999; Timmons et al., 2012).
Several studies have evaluated their effect on the growth capacity
of the gastrointestinal mucosa, which has the highest turnover
in human body (approximately every 78 h), and have shown a
positive role for PA both in conditions of physiological growth
and in mucosal repair. In fact, lack of PA stabilizes p53 and JunD,
thereby inhibiting intestinal epithelial re-growth (Li et al., 2001,
2002). In addition, since appropriate PA levels are essential for
the stability of occludin and adherens junctions (Guo et al., 2003,
2005), as well as for c-myc-mediated E-cadherin transcription
(Liu et al., 2005, 2009), PA might have a beneficial effect
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FIGURE 3 | Mode of action of spermidine through TCPTP-activation. In the cytoplasm, activated TCPTP down-regulates signal transduction pathways
downstream EGFR, TGF-βR, the Frizzled/Wnt/Lrc complex, and most of conjugated signaling effectors of EGF, IFN-γ, TNF-α, IL-6, and IL-1β/TGF-β. Inhibition occurs
by dephoshorylation of key components of JAK1/jnk/jun/fos/p38, noncanonical Ras/Raf/MEK/ERK, and PI3K/PIP3/Akt pathways, as well as the nucleus-addressably
proteins STATs and R-SMADs. In particular, dephosphorylated R-SMADs prevent coSMAD binding and the R-SMAD/coSMAD complexes to accumulate in the
nucleus and act as transcription factors in TGF-β/Smads and p53 loci via Snail/Slug and Zeb1. Their inhibited access to chromatin represses detachment, migration,
and EMT proteins like fibronectin, vimentin, MMP2/9, N-cadherin, and collagens I/III. Phenotypic involution toward EMT is prevented, whereas spermidine
epigenetically favors the expression of c-fos, c-jun, and c-myc. Outcomes consist of the enhanced expression of tight junctional and adherens proteins: claudin-1,
occludin, ZO-1/2/3, and E-cadherins (in bold). EGF, epidermal growth factor; EGFR, EGF receptor; TGF-β, transforming growth factor β; TGF-βR, TGF-β receptor,
TGFβRI/II, TGFR tetramer; TAK1, TGFβ-activated kinase 1; IFN-γ, interferon-γ; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6;, IL-1β, interleukin-1β; Wnt/Lrc,
ligand to Frizzled receptor; Jnk/Jun/fos/p38 signal transduction proteins; ERK, extracellular signal-regulated kinase; PI3K, phosphatidylinositol-3’- kinase; PIP3,
phosphatidylinositol(3,4,5) trisphosphate; Akt, activator kinase; JAK, Janus kinase; R-SMAD and coSMAD, family of transcriptional smadx activator protein/cofactors;
STATs, signal transducers/activators of transcription; GSK3, glycogen synthase kinase; ZO, zonula occludens; Snail/Slug, transcription factors; Zeb, zinc finger E box
binding homeobox; TGFβ/Smads/p53/p21, genes for chemotaxis; c-fos/c-jun, gene expressing junctional proteins; MMP, matrix metalloproteinases; EMT,
epithelial-to-mesenchymal transition.
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in maintaining the intestinal epithelial barrier function. This
“improved barrier” theory has a sound background since PA, and
particularly spermidine, assist cell-cell interactions by promoting
the expression of adherens and tight junction proteins in the
intestine (Wang, 2005).
Another mode of action of PA in ensuring mucosal integrity
was revealed by a study showing that PA are needed for
microtubule (MT) formation during gastric mucosal healing
(Banan et al., 1998). These results are in line with the
essential role of PA in cytoskeleton assembly (Anderson et al.,
1985). In this context, the facilitated tubulin attraction, MT
nucleation, and elongation promoted by PA, and particularly
by spermidine, occur through plain electrostatic mechanism
(Mechulam et al., 2009; Hamon et al., 2011). Indeed, PA depletion
causes the disappearance of actin filaments and MT in CHO cells
(Pohjanpelto et al., 1981), while PA was found to associate to
anionic MT via promoted formation of MAP4 (MT-associated
protein 4) and redistribution of EB1 (end-binding protein 1) and
MT plus-end-binding protein (Savarin et al., 2010). Therefore,
as gap junctions require extended MT up to cell periphery
(Shaw et al., 2007), it is possible to envisage a process in which
PA-induced MT elongation and modulation sustain epithelial
integrity.
In these settings, TCPTP agonism enacted by spermidine
matches 40 years of research on bowel homeostasis, and also
explains the molecular mechanisms underlying the contribution
of spermidine to the alleviation of pro-inflammatory signals and
intestinal barrier dysfunction. In fact, on a functional level, it
has been shown that spermidine in co-incubation experiments
with IFN-α protects intestinal epithelial barrier functionality in
the setting of inflammation, by limiting the increase of epithelial
permeability (Penrose et al., 2013). Moreover, spermidine
administration decreased mucosal damage and weight loss in a
mouse model of colitis (Moron et al., 2013).
Finally, the anti-“inflammaging” action and barrier
reinforcement triggered by TCPTP agonism (or autophagy,
see below) may account for the positive effects of enhanced
spermidine/PA production in the luminal tracts on longevity
(Matsumoto et al., 2011; Kibe et al., 2014) and tumorigenesis
(Soda et al., 2013).
AUTOPHAGY: PROMOTION BY
SPERMIDINE AND ROLE IN LUNG
DISORDERS
Autophagy is a self-cleaning process that represents an adaptive
response elicited by “anti-nutrient” signals and starvation, and
contributes to longevity (Eisenberg et al., 2009). Its role in COPD
and asthma is complex and not fully clear (Poon A., et al.,
2012; Poon A. H., et al., 2012; Jyothula and Eissa, 2013). Among
the factors involved, oxidative stress may act both as autophagy
promoter via AMP-activated protein kinase (AMPK) signaling
(Wu et al., 2014), and repressor, in analogy with cytokine effectors
that dock EGFR and TFG-βR (Khan et al., 2008; Tripathi et al.,
2013). Conversely, particulate matter 2.5 (PM2.5), an aggravating
factor for most obstructive airways diseases, seems to favor
autophagy, as it inhibits the PI3K/AKT/ mammalian target of
rapamycin type 1 (mTOR) pathway (Liu et al., 2015). Overall,
the overactive immune responses present in airway pathologies
display an array of divergent pro- and anti-autophagy effects
(Figure 4).
As noted by Mercado et al. (2015), current information
about the role of autophagy in bronchial and alveolar epithelial
cells in lungs of patients with active COPD is divided into
evidence showing that excessive autophagy and mitophagy
results in cell death, and proof that pathological changes
are the consequence of an underlying defective autophagy.
Insufficient autophagy is thought to lead to involution patterns
including stem cells depletion, reduced antioxidant responses,
and defective mitochondrial function, which may contribute to
progressive cell senescence (Fujii et al., 2012; Ito et al., 2012;
Takasaka et al., 2014). Conversely, excess autophagy leads to
shortening and, finally, total consumption of cilia components,
called “ciliophagy” (Lam et al., 2013). Epithelial cells from mice
lacking LC3B, which is required for autophagosome formation,
are protected from cigarette-smoke (CS)-induced autophagy
and resist emphysema. However, the effect of CS-promoted
ciliophagy on mucociliary clearance is reversible and only lately
associated with the increased apoptosis of ciliated cells that
occurs when accumulation of CS-denatured protein exceeds
cellular degradative capacity. This suggests that ciliophagy only
partially contributes to airway dysfunction (Cloonan et al., 2014)
and might be a regulatory pattern in ciliogenesis through the
control of ciliary proteins (Orhon et al., 2015).
In clinical specimens of COPD patients, autophagy markers
are upregulated at early stages of disease progression whereas
caspases are activated later on. This might indicate that
autophagy either precedes apoptosis in response to disease
stress on lung, or is an attempt to self-protect from CS
stress (Ryter et al., 2009). Autophagy may altogether act
as a clearance mechanism, since macrophages in lung
biopsies from non-COPD smokers showed impaired
autophagic efficiency and debris accumulation (Monick
et al., 2010).
With regard to the protective role of spermidine in airway
diseases, it is of interest to underline that the promotion
of authophagy is another key aspect of spermidine activity
(Eisenberg et al., 2009; Morselli et al., 2011; Minois, 2014). The
beneficial impact exerted by spermidine in several model systems,
including improved fertility (Bauer et al., 2013) and retained
memory in aging (Gupta et al., 2013) or reverted age-dependent
arterial degeneration in murine arteriosclerosis (LaRocca et al.,
2013), correlates with the activity of autophagy promotion.
Outcomes are comparable to starvation and caloric restriction
mimetics, a new class of autophagy-inducing therapeutics with
potential clinical utility in diabetes, metabolic syndrome, and
cardiovascular diseases (Madeo et al., 2014). Autophagy is
repressed by mTOR complex (mTORC1), but is activated by
pathways involving the “longevity factor” Sirt1 or the “energy
sensor” AMPK (Cetrullo et al., 2015). However, spermidine
appears to function as an autophagy inducer not by directly
affecting the mTOR pathway, but rather by inducing a status
of protein hypoacetylation via inhibition of histone acetylases
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FIGURE 4 | Role of Spermidine-TCPTP in the complex dynamics of pro- and anti-autophagic factors. Autophagy requires the coordinated activation of
multiple factors. Several Atg proteins are recruited within the ULK1 complex during vesicle nucleation and within the ubiquitin-like conjugation systems Atg12-UBL
and LC3-UBL during phagophore elongation, and completion. The main autophagy repressor, mTORC1, exerts its inhibitory action by phosphorylating ULK1. mTOR
interacts with the proline-rich Akt, newly synthesized in the PI3K/PI3P/Akt pathway, downstream of EGFR, and TGF-βR signaling, which in turns responds (inter-alia)
to cytokines such as IFN-γ, TNF-α, IL-6, and IL-1β/TGF-β. A mTORC1 antagonist and autophagy promoter is AMPK. Upon activation from non-immune stress factors
including starvation, hypoxia, ROS (e.g., O−2 , H2O2, OH
.), and RNS (e.g., peroxynitrite) via ATM/LKB1, AMPK prompts autophagy. AMPK is directly involved in the
formation of ULK1 complex and cooperates with Becl 1-VPS34 complexes, pro-autophagy adapters involved in nucleation of autophagosome membrane. While ROS
simulate EGFR activation, other environmental stressors (e.g., MP2.5) have an opposite effect, by inhibiting PI3K/PI3P/Akt. Agonistic activity of spermidine on TCPTP
would down-regulate both EGFR and TGF-βR and their downstream effectors. Yet, the prevalent, established mode of action of spermidine in autophagy entails the
inhibition of EP300, leading to reduced histone acetylation (particularly histone-3), and, consequently, to Atg (particularly Atg7) expression and autophagosome
elongation and closure. Spermidine activity on EP300 is similar to that exerted by low cytoplasmatic levels of Ac-CoA due to scarce nutrient availability, a situation that
also activates AMPK. Ac-CoA, acetyl-coenzyme A; ROS, reactive oxygen species; RNS, reactive nitrogen species; O−2, superoxide anion; H2O2; hydrogen peroxide;
OH., hydroxyl radical; PM2.5, particulate matter 2.5; IFN-γ, interferon-γ; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6;, IL-1β, interleukin-1β; EGFR, epidermal
growth factor receptor; TGF-βR, transforming growth factor β receptor; ULK1/2, UNC-51-like kinases 1/2; ATM ataxia telangiectasia mutated kinase; LKB1, upstream
kinase of AMPK; AMPK adenosine monophosphate-activated protein kinase; TSC2, tuberous sclerosis 2; mTORC1, mammalian target of rapamycin type-1 complex;
EP300, E1A-binding protein p300; Beclin 1-VPS34 complex, Beclin 1-ATG14L; VPS34, class III phosphatidylinositol 3-kinase; Atg autophagy related proteins;
ULK1-complex, Atg13-FIP200-Atg101-Atg14L conjugation system; FIP200, FAK-family interacting protein of 200 kDa; Atg12-UBL system,
Atg5-Atg12-Atg10-Atg16-Atg7 pathway; LC3-UBL system, LC3-Atg3-Atg4-Atg7-PE pathway; LC3, microtubule-associated protein light chain 3; PE,
phosphatidylethanolamine; HAT, histone acetyltrasferase.
(Morselli et al., 2009), such as EP300 acetyltransferase, an
endogenous repressor of autophagy (Pietrocola et al., 2015).
As EP300 is strictly regulated by cytoplasmatic acetyl-
coenzymeA levels (Marino et al., 2014b) and nutrient availability,
this confirms the “starvation-mimicking” property of spermidine
(Figure 4).
In line with the proposed role of the crosstalk between
spermidine and TCPTP (see above), recent studies have
demonstrated that TCPTP also regulates autophagy in human
intestinal cells and other cell types (Scharl and Rogler,
2012; Scharl et al., 2012). TCPTP dysfunction correlated with
impaired autophagosome formation and defective autophagy,
thus contributing to the development and perpetuation of
chronic inflammatory disorders, such as inflammatory bowel
diseases (Spalinger et al., 2015). Conversely, high TCPTP
levels were found to increase autophagy (Aradi et al., 2015).
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FIGURE 5 | Effects of unbound spermidine on cellular fate. The multimodal activity of spermidine primarily relies on local concentration, recognized as a critical
factor. The polycationic spermidine tends to saturate anionic molecules, partly in the phospholipid (PL) bilayer within cell membranes, partly coupling phosphate and
adenosine triphosphate (ATP); yet, it is mostly associated with the core anionic biopolymers, i.e., RNA, but also DNA and histones, therefore modifying chromatin
conformation. Ultralow doses of exogenous spermidine double the content of free (unbound) spermidine. Excess and paucity levels are closer than previously
deemed, as a change in the micromolar range may switch a trophic (or growth promoting) activated state pattern into an inflammatory-apoptotic pattern.
Concentrations are just indicatory, as levels of spermidine in cytosol and nucleus differ from tissues to tissues and during lifespan.
Therefore, it may be speculated that spermidine can promote
the autophagic process at least in part via TCPTP; however,
the role of TCPTP in spermidine-induced autophagy remains
to be explored, together with a careful examination of the
effective dose. Indeed, manipulation of autophagy is a delicate
matter, as this process can generally antagonize degenerative
processes, but its excessive induction may result in maladaptive
tissue remodeling (Fimia and Piacentini, 2010; Marino et al.,
2014a; Filomeni et al., 2015; Maiuri and Kroemer, 2015).
Thus, it is important to monitor carefully basal levels of
autophagy and its flux as a function of time and dosage of
stimulant. This can be carried out with experimental models
usually employed to study chronic epithelial disorders, such as
in vitro cultures of immortalized human bronchial epithelial
cell line (BEAS 2B cells) or primary cells from specimens
obtained from donors for lung transplantation (Kinnula et al.,
1994). Genetic deletion of specific autophagy proteins in animal
models (Cann et al., 2008) may also be useful to study the
involvement of this process in airway disorders and the possible
modulation by spermidine treatment. Keeping in mind the
complexity of the autophagic process, multiple, short-term
and long-term assays are recommended to monitor autophagy,
including flux measurements in normal, and blocked turnover
conditions. Indeed, autophagy flux is the entire process, from
autophagosome biogenesis to cargo digestion by lysosomes, and
macromolecule release back into the cytosol. Therefore, the
evaluation of lysosomal competence as the final stage in this
process is essential for a correct interpretation of the results.
Finally, human lung specimens from patients can be analyzed for
autophagy markers, such as increased autophagosome numbers
and increased expression of LC3B-II, the active form of LC3B,
or assayed by transmission electronic microscopy to monitor
autophagic structures. This issue, i.e., the different outcome
of autophagy as a function of its level, introduces dose-
finding concepts in pursuit of the therapeutic use of exogenous
spermidine, and underscores the need for fine-tuning the dose
of spermidine in clinical settings, as further detailed in the next
paragraph.
THERAPEUTIC APPLICATIONS
Spermidine is currently used as dietary supplements and topical
hair-growth promoter, with proven efficacy in vitro (Ramot et al.,
2011) and in clinical settings (Rinaldi et al., 2004); therefore, the
molecule has a proven history of safe long-term use in consumer
products.
Over the past 5 years our group has set up a therapeutic
platform based on spermidine. We have focused on the
preparation and set up of a variety of supramolecular complexes
(SMC) in which spermidine was bound to different polymers,
and our studies showed that sustained delivery from SMC is
able to optimize the effect of spermidine on fibroblast viability
(Ghisalberti et al., 2013). The sustained-release efficiency is
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FIGURE 6 | Exogenous spermidine may interrupt the vicious cycling in chronic airways diseases. Locally delivered spermidine works both as a TCPTP
agonist and stimulator of the expression of genes coding for adherens and tight junction proteins. The former effect down-regulates the secondary growth factor
signaling pathways, such as epidermal growth factor (EGF) and transforming growth factor-β (TGF-β) receptors and relevant pathways. This repression prevents the
epithelial-to-mesenchymal transition to occur, which would further impair the epithelial impermeability and contribute to chronic remodeling and fibrosis. Strengthening
the airways epithelial barrier translates into a reduced exposure to allergens, stressor proteins, and reactive oxygen species.
unrelated to the matrix polymer, since a variety of anionic or
SMC-forming carriers (e.g., spermidine-hyaluronate, Spd-HA)
afforded similar results.
A pilot study on vestibulitis, in which pain relief was assessed
in terms of absolute and relative effect size compared to present
and purported drugs for vulvodynia (Murina et al., unpublished),
showed that a regimen of 1 µmole of spermidine (administered
as gels containing Spd-HA) at 3 doses/week for 1month, followed
by 2 doses/week for another month was effective in blunting
pain, assessed by the visual analogic score, and improving
dyspareunia, thus indicating that spermidinemay be envisaged as
a new paradigm in widespread female disorders. Indeed, another
pilot study in post-menopausal vaginal atrophy showed that
a similar regimen, but by intravaginal application, resulted in
clinical outcomes close to those of estrogenic and pro-estrogenic
therapies (Carena Maini et al., unpublished), yet avoiding
estrogenic risks while retaining comparable efficacy and duration.
Other exploratory trials to evaluate the efficacy of spermidine
complexed to SMC for atrophic or degenerative disorders, such
as periodontitis and osteoarthritis are ongoing, following a series
of studies on joint metabolism and mesenchymal differentiation
(Borzi et al., 2014).
The question of “how a common metabolite at sub-
micromolar dose becomes of therapeutic relevance” may have an
answer in the localization of spermidine, which is 90% bound to
intracellular anionic moieties (Watanabe et al., 1991; Matthews,
1993). Therefore, even a low dose in the micromolar range
can lead to a meaningful increase, actually doubling the free
pool and thereby impacting on overall cell physiology. Hence,
spermidine “therapeutic window” may reside at sub-micromolar
level (Figure 5). In addition, this dosage prevents plain toxicity
(Foster et al., 1990) while impeding apoptotic/inflammatory
cascades to prevail (Silva et al., 2011).
Interestingly, it has been shown that low doses of spermidine
in the micromolar range are sufficient to activate TCPTP
(Mattila et al., 2010), thereby triggering the downstream signaling
pathways discussed above, and also activating autophagy, which
has been shown to be induced by low doses of spermidine
(Eisenberg et al., 2009). Activated TCPTP moderates most
destabilizing processes set in motion by secondary growth and
stress factors in asthma and COPD airways, while sustaining
epithelial barrier repair and reinforcement. Moreover, the
addition of spermidine should contrast increasing polyamine
biosynthesis, which may negatively impact on NO formation.
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Although only preliminary data are presently available, it can
be predicted and experimentally tested that sub-micromolar
doses of spermidine in SMC, possibly delivered using an
inhalator, may be beneficial in bronchial repair to improve
patient outcomes in chronic lung diseases, including asthma
and COPD.
CONCLUSIONS
A reparative approach of disrupted epithelium in obstructive
airway diseases may afford protection and more lasting results
than therapies such as corticosteroids or immunosuppressant
drugs. PA have been proposed as potential therapy in airway
diseases. However, it has also been claimed that increased
PA biosynthesis exacerbates lung diseases, as the PA synthetic
pathway competes for L-arginine at the expenses of NO
production, thus resulting in bronchoconstriction. Moreover,
the pathways involved in the beneficial effect of PA in airway
diseases are still poorly defined and controversial. A recent
study showing a direct interaction between spermidine and
TCPTP may place the beneficial role of PA in airway epithelial
integrity in a coherent framework. In fact, the dephosphorylating
activity of TCPTP represses the signaling cascade that activates
genes favoring cell detachment and epithelial-to-mesenchimal
transition, while increasing the expression of adhesion and tight
junction proteins. Moreover, the protective effect of spermidine
may also depend on the capacity of TCPTP to trigger autophagy.
As such, TCPTP agonism may provide a unifying explanatory
view of a vast array of biological features of spermidine and
foster a mechanism-guided application of PA in COPD. Since,
doses of spermidine in the micromolar range are sufficient
to activate TCPTP and downstream signaling pathways, the
sustained delivery of very low amounts of spermidine from
SMC may provide an optimal pharmacologic profile for the
treatment of obstructive airway diseases while avoiding potential
harmful effects of excess PA, as suggested by preliminary evidence
obtained in vitro and in vivo. Therefore, we propose spermidine
in a sustained release modality as a novel therapeutic approach
for airway barrier remodeling, based on a novel mode of action:
TCPTP agonism. The overall features of inhaled spermidine
(Figure 6) appear promising in order to provide hope for chronic
lung sufferers, who are still in need of novel therapies providing
more appropriate, long-lasting benefits to effectively treat chronic
lung diseases.
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